The investigation determined that (b)(6) results were obtained from two patient samples as part of internal stability testing, using vitros ahbs reagent with a vitros 3600 immunodiagnostic system.A definitive assignable cause could not be determined.Precision testing was not performed to verify that the instrument was operating as expected, therefore atypical instrument performance cannot be ruled out as contributing to the event.Relevant quality control data was not available, therefore the performance of the vitros ahbs reagent could also not be evaluated and a reagent issue could not be ruled out as a contributing factor.
|
An ortho quality engineer obtained two (b)(6) results from two negative panel patient samples processed as part of routine stability testing, using vitros ahbs reagent in combination with a vitros 3600 immunodiagnostic system.The (b)(6) vitros ahbs result was (b)(6) when compared to (b)(6) vitros ahbs results from repeat testing.The results obtained are as follows: (b)(6).Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples.The (b)(6) results were obtained as part of internal stability testing and were not reported from the laboratory.There was no allegation of patient harm as a result of the events.However, it cannot be concluded that patient samples would not be affected if the events were to recur undetected in a clinical setting.(b)(4).
|